Cat. No. 5051
Chemical Name: (2S)-2-[[[(2S)-1-[(3,5-Dichlorophen
Biological ActivityHighly selective and potent inhibitor of integrin α4β1 (Very Late Antigen-4; VLA-4) (Kd < 10 pM). Selectively binds α4β1 over a range of other integrins (IC50 values are 1.8, 138, 1053, > 500 and > 10,000 nM for α4β1, α9β1, α2β1, α4β7 and αIIbβ3, respectively). Induces a 30-fold increase in mobilization of murine hematopoietic stem and progenitor cells; displays a 3-fold additive effect with AMD 3100 (Cat. No. 3299).
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Ramirez et al (2009) BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells. Blood. 1340 1340. PMID: 19571319.
Xu et al (2008) A chemical approach to stem-cell biology and regenerative medicine. Nature 453 338. PMID: 18480815.
Leone et al (2003) An assessment of the mechanistic differences between two integrin α4β1 inhibitors, the monoclonal antibody TA-2 and the small molecule BIO5192, in rat experimental autoimmune encephalomyelitis. J.Pharmacol.Exp.Ther. 305 1150. PMID: 12626659.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses BIO 5192 from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: BIO 5192, supplier, BIO5192, Inflammatory, mobilization, hematopoietic, stem, progenitors, AMD3100, plerixafor, HSPCs, highly, selective, potent, inhibitor, of, integrin, ⓮⓵, VLA-4, Very, Late, Antigen, 4, mobilisation, haematopoietic, inhibitors, inhibits, Tocris Bioscience, Integrin Receptor Inhibitor products
Find multiple products by catalog number
New Products in this Area
Potent and selective inhibitor of integrins αvβ3 and αvβ5SM 324405
Potent TLR7 agonistRS 09
TLR4 peptide agonist; acts as an adjuvant in vivo
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.